This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/s2213-8587(21)00242-4
Other

Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

..., Robert D. Toto
72
The Lancet Diabetes & Endocrinology44.00
Volume: 9, Issue: 11, Pages: 743 - 754
Published: Oct 6, 2021
Abstract
No abstract.
Paper Fields
Paper Details
Title
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
DOI
doi.org/10.1016/s2213-8587(21)00242-4
Published Date
Oct 6, 2021
Journal
The Lancet Diabetes & Endocrinology
Volume
9
Issue
11
Pages
743 - 754
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.